FYERS
Home
/
Stocks
/
Results
/
Lincoln Pharmaceuticals Results

Lincoln Pharmaceuticals Results

Financial overview

CAGR%
Sales
Profits
Returns
ROE
10Y5Y3YTTM
9%10%10%7%
19%10%6%-12%
9%9%6%10%
17%16%15%13%

Peer Comparison

Symbol
SUNPHARMA
DIVISLAB
TORNTPHARM
ZYDUSLIFE
CIPLA
LAURUSLABS
MANKIND
DRREDDY
AUROPHARMA
LUPIN
LINCOLN
PriceM.Cap (₹)PE RatioEPS (₹)EV/EBITDAAnnual PAT
1,849.9₹447476 Cr3712.0762.82₹11479 Cr
9,602₹254764 Cr87.134.04128.41₹2568 Cr
4,928.5₹189423 Cr86.8516.7297.06₹2163 Cr
1,180.3₹116658 Cr25.859.4262.53₹5040 Cr
1,399₹111484 Cr33.089.7757.87₹3879 Cr
2,026.2₹109943 Cr100.556.829.25₹889 Cr
2,500₹101712 Cr49.7913.7571.08₹1913 Cr
1,200.4₹101005 Cr31.355.3263.99₹4196 Cr
1,716₹99253 Cr26.7317.9596.84₹3505 Cr
2,100.7₹96031 Cr17.3730.95154.35₹5333 Cr
594.65₹1208 Cr12.5218.0955.6₹88 Cr

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%

Balance Sheet

Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Minority Interest
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Miscellaneous Expenses not written off
Total Assets
Book Value
Adjusted Book Value
Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010Mar 2009
—————————————————
₹20 Cr₹20 Cr₹20 Cr₹20 Cr₹20 Cr₹20 Cr₹20 Cr₹20 Cr₹20 Cr₹16 Cr₹16 Cr₹16 Cr₹16 Cr₹16 Cr₹16 Cr₹11 Cr₹8 Cr
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹8 Cr₹0₹0₹0₹0₹0₹0₹1 Cr
₹652 Cr₹573 Cr₹482 Cr₹413 Cr₹346 Cr₹293 Cr₹249 Cr₹204 Cr₹172 Cr₹117 Cr₹95 Cr₹83 Cr₹73 Cr₹64 Cr₹61 Cr₹42 Cr₹28 Cr
₹652 Cr₹573 Cr₹482 Cr₹413 Cr₹346 Cr₹293 Cr₹249 Cr₹204 Cr₹172 Cr₹117 Cr₹95 Cr₹83 Cr₹73 Cr₹64 Cr₹61 Cr₹42 Cr₹28 Cr
₹672 Cr₹593 Cr₹502 Cr₹433 Cr₹366 Cr₹313 Cr₹269 Cr₹224 Cr₹192 Cr₹141 Cr₹111 Cr₹99 Cr₹89 Cr₹81 Cr₹77 Cr₹53 Cr₹36 Cr
₹0₹0₹0₹0₹0₹38 L₹36 L₹33 L₹30 L₹19 L₹3 Cr₹4 Cr₹4 Cr₹4 Cr₹0₹0₹0
₹0₹0₹0₹0₹14 L₹85 L₹2 Cr₹7 Cr₹12 Cr₹24 Cr₹15 Cr₹16 Cr₹14 Cr₹12 Cr₹3 Cr₹26 Cr₹12 Cr
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹10 Cr₹3 Cr₹3 Cr₹2 Cr₹2 Cr₹2 Cr₹4 Cr
₹13 Cr₹11 Cr₹8 Cr₹6 Cr₹6 Cr₹5 Cr₹6 Cr₹7 Cr₹6 Cr₹7 Cr₹5 Cr₹4 Cr₹5 Cr₹5 Cr₹4 Cr₹3 Cr₹2 Cr
₹5 Cr₹4 Cr₹5 Cr₹5 Cr₹4 Cr₹4 Cr₹4 Cr₹4 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹0₹0
₹73 L₹10 L₹25 Cr₹0₹16 Cr₹33 Cr₹17 Cr₹7 Cr₹10 Cr₹0₹0₹0₹0₹0₹0₹0₹0
₹19 Cr₹15 Cr₹38 Cr₹11 Cr₹26 Cr₹43 Cr₹28 Cr₹25 Cr₹32 Cr₹34 Cr₹33 Cr₹26 Cr₹25 Cr₹22 Cr₹11 Cr₹30 Cr₹18 Cr
—————————————————
₹85 Cr₹72 Cr₹51 Cr₹72 Cr₹57 Cr₹51 Cr₹44 Cr₹43 Cr₹32 Cr₹30 Cr₹45 Cr₹67 Cr₹48 Cr₹42 Cr₹23 Cr₹18 Cr₹11 Cr
₹15 Cr₹15 Cr₹15 Cr₹10 Cr₹13 Cr₹9 Cr₹11 Cr₹11 Cr₹13 Cr₹15 Cr₹12 Cr₹14 Cr₹16 Cr₹16 Cr₹12 Cr₹4 Cr₹63 L
₹0₹1 Cr₹2 Cr₹2 Cr₹0₹4 Cr₹30 Cr₹49 Cr₹45 Cr₹53 Cr₹51 Cr₹48 Cr₹55 Cr₹47 Cr₹40 Cr₹0₹0
₹31 Cr₹29 Cr₹29 Cr₹27 Cr₹24 Cr₹16 Cr₹15 Cr₹10 Cr₹9 Cr₹2 Cr₹7 Cr₹2 Cr₹27 L₹0₹2 Cr₹6 Cr₹7 Cr
₹131 Cr₹117 Cr₹96 Cr₹111 Cr₹95 Cr₹80 Cr₹100 Cr₹113 Cr₹99 Cr₹100 Cr₹114 Cr₹131 Cr₹118 Cr₹105 Cr₹77 Cr₹28 Cr₹19 Cr
₹822 Cr₹725 Cr₹637 Cr₹555 Cr₹487 Cr₹437 Cr₹399 Cr₹363 Cr₹324 Cr₹275 Cr₹262 Cr₹260 Cr₹237 Cr₹212 Cr₹165 Cr₹111 Cr₹73 Cr
₹3 Cr₹23 L₹23 L₹23 L₹1 Cr₹2 Cr₹2 Cr₹23 Cr₹20 Cr₹15 Cr₹13 L₹13 L₹0₹0₹5 Cr₹4 Cr₹5 Cr
₹0₹1 Cr₹2 Cr₹2 Cr₹52 L₹5 Cr₹34 Cr₹61 Cr₹64 Cr₹78 Cr₹76 Cr₹68 Cr₹76 Cr₹69 Cr₹46 Cr₹27 Cr₹16 Cr
—————————————————
₹252 Cr₹237 Cr₹197 Cr₹171 Cr₹142 Cr₹147 Cr₹138 Cr₹128 Cr₹108 Cr₹121 Cr₹88 Cr₹82 Cr₹79 Cr₹49 Cr₹37 Cr₹28 Cr₹22 Cr
₹70 Cr₹57 Cr₹47 Cr₹39 Cr₹31 Cr₹24 Cr₹17 Cr₹11 Cr₹5 Cr₹22 Cr₹22 Cr₹17 Cr₹14 Cr₹11 Cr₹9 Cr₹7 Cr₹6 Cr
₹182 Cr₹179 Cr₹151 Cr₹132 Cr₹111 Cr₹123 Cr₹121 Cr₹117 Cr₹103 Cr₹98 Cr₹66 Cr₹65 Cr₹65 Cr₹38 Cr₹28 Cr₹21 Cr₹17 Cr
₹4 Cr₹3 Cr₹7 Cr₹16 Cr₹2 Cr₹4 L₹2 Cr₹29 L₹7 Cr₹3 Cr₹3 Cr₹2 Cr₹2 Cr₹14 Cr₹4 Cr₹1 Cr₹0
₹26,000₹26,000₹26,000₹26,000₹40,000₹9 L₹9 L₹9 L₹9 L₹55,400₹55,400₹41 L₹41 L₹41 L₹34,200₹34,200₹19,200
₹26,000₹26,000₹26,000₹26,000₹40,000₹9 L₹9 L₹9 L₹9 L₹55,400₹55,400₹41 L₹41 L₹41 L₹34,200₹34,200₹19,200
₹111 Cr₹80 Cr₹88 Cr₹32 Cr₹47 Cr₹51 Cr₹36 Cr₹19 Cr₹24 Cr₹27 Cr₹12 Cr₹43 Cr₹46 Cr₹39 Cr₹13 Cr₹0₹0
₹0₹9,000₹6,000₹2 Cr₹45 L₹3 L₹33 L₹34 L₹36 L₹0₹0₹0₹0₹0₹60,899₹0₹0
₹297 Cr₹263 Cr₹245 Cr₹182 Cr₹160 Cr₹174 Cr₹159 Cr₹136 Cr₹134 Cr₹128 Cr₹81 Cr₹111 Cr₹114 Cr₹91 Cr₹45 Cr₹22 Cr₹17 Cr
—————————————————
₹174 Cr₹139 Cr₹91 Cr₹97 Cr₹81 Cr₹34 Cr₹18 Cr₹11 Cr₹10 Cr₹0₹0₹0₹0₹0₹0₹0₹0
₹79 Cr₹77 Cr₹70 Cr₹73 Cr₹47 Cr₹47 Cr₹36 Cr₹45 Cr₹37 Cr₹27 Cr₹22 Cr₹24 Cr₹19 Cr₹21 Cr₹26 Cr₹23 Cr₹14 Cr
₹166 Cr₹162 Cr₹136 Cr₹116 Cr₹113 Cr₹101 Cr₹122 Cr₹109 Cr₹91 Cr₹81 Cr₹119 Cr₹89 Cr₹75 Cr₹65 Cr₹40 Cr₹31 Cr₹23 Cr
₹22 Cr₹14 Cr₹34 Cr₹19 Cr₹14 Cr₹15 Cr₹8 Cr₹15 Cr₹12 Cr₹13 Cr₹12 Cr₹10 Cr₹15 Cr₹17 Cr₹13 Cr₹13 Cr₹5 Cr
₹3 Cr₹2 Cr₹2 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹66 L₹5 L₹0₹0₹0₹0₹0₹0₹0
₹81 Cr₹70 Cr₹57 Cr₹68 Cr₹72 Cr₹64 Cr₹54 Cr₹45 Cr₹39 Cr₹26 Cr₹29 Cr₹26 Cr₹14 Cr₹18 Cr₹41 Cr₹21 Cr₹14 Cr
₹525 Cr₹463 Cr₹391 Cr₹373 Cr₹328 Cr₹263 Cr₹239 Cr₹227 Cr₹190 Cr₹147 Cr₹181 Cr₹149 Cr₹123 Cr₹122 Cr₹120 Cr₹89 Cr₹56 Cr
₹394 Cr₹346 Cr₹295 Cr₹262 Cr₹233 Cr₹182 Cr₹139 Cr₹113 Cr₹90 Cr₹47 Cr₹67 Cr₹18 Cr₹5 Cr₹17 Cr₹43 Cr₹61 Cr₹37 Cr
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹81,199₹1 L
₹822 Cr₹725 Cr₹637 Cr₹555 Cr₹487 Cr₹437 Cr₹399 Cr₹363 Cr₹324 Cr₹275 Cr₹262 Cr₹260 Cr₹237 Cr₹212 Cr₹165 Cr₹111 Cr₹73 Cr
₹335₹296₹251₹216₹183₹157₹135₹112₹96₹82₹68₹61₹55₹50₹47₹47₹47
₹335₹296₹251₹216₹183₹157₹135₹112₹96₹82₹68₹61₹55₹50₹47₹47₹47

Cash Flow

Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Cash & Cash Equivalent on Amalgamation / Take over / Merger
Closing Cash & Cash Equivalent
Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010Mar 2009
₹109 Cr₹122 Cr₹100 Cr₹96 Cr₹84 Cr₹67 Cr₹62 Cr₹46 Cr₹37 Cr₹33 Cr₹20 Cr₹12 Cr₹10 Cr₹5 Cr₹8 Cr₹9 Cr₹7 Cr
₹96 L-₹17 Cr-₹23 L₹1 Cr₹5 Cr₹9 Cr₹9 Cr₹12 Cr₹11 Cr₹14 Cr₹11 Cr₹13 Cr₹9 Cr₹14 Cr₹7 Cr₹1 Cr₹2 Cr
₹9 Cr-₹16 Cr-₹31 Cr₹2 Cr₹20 L₹14 Cr-₹1 Cr-₹22 Cr-₹13 Cr₹5 Cr-₹3 Cr-₹18 Cr-₹32 Cr-₹6 Cr-₹48 Cr-₹18 Cr-₹5 Cr
₹119 Cr₹89 Cr₹69 Cr₹100 Cr₹89 Cr₹90 Cr₹70 Cr₹36 Cr₹35 Cr₹52 Cr₹28 Cr₹7 Cr-₹14 Cr₹13 Cr-₹33 Cr-₹8 Cr₹4 Cr
₹93 Cr₹63 Cr₹39 Cr₹76 Cr₹69 Cr₹75 Cr₹53 Cr₹27 Cr₹25 Cr₹45 Cr₹25 Cr₹5 Cr-₹16 Cr₹12 Cr-₹34 Cr-₹11 Cr₹2 Cr
-₹79 Cr-₹57 Cr-₹37 Cr-₹78 Cr-₹64 Cr-₹31 Cr-₹18 Cr-₹12 Cr-₹25 Cr-₹42 Cr₹7 Cr₹1 Cr-₹16 Cr-₹27 Cr-₹11 Cr-₹6 Cr-₹4 Cr
-₹6 Cr-₹5 Cr-₹5 Cr-₹3 Cr-₹6 Cr-₹38 Cr-₹36 Cr-₹11 Cr₹30 L-₹3 Cr-₹32 Cr-₹11 Cr₹29 Cr₹16 Cr₹45 Cr₹25 Cr₹3 Cr
₹8 Cr₹70 L-₹2 Cr-₹5 Cr-₹70 L₹7 Cr-₹1 Cr₹3 Cr-₹14 L-₹41 L-₹96 L-₹4 Cr-₹3 Cr₹82 L-₹9 L₹9 Cr₹1 Cr
₹6 Cr₹5 Cr₹7 Cr₹11 Cr₹12 Cr₹5 Cr₹7 Cr₹3 Cr₹3 Cr₹4 Cr₹5 Cr₹9 Cr₹12 Cr₹12 Cr₹12 Cr₹5 Cr₹3 Cr
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹9 L₹0₹0₹0₹0₹0₹0₹0
₹13 Cr₹6 Cr₹5 Cr₹7 Cr₹11 Cr₹12 Cr₹5 Cr₹7 Cr₹3 Cr₹3 Cr₹4 Cr₹5 Cr₹9 Cr₹12 Cr₹12 Cr₹13 Cr₹5 Cr

Fundamental Ratios

Consolidated
Standalone

Share Price Live Stats

Open (₹)603.00
Volume (₹)16,062.00
High (₹)604.35
Upper Circuit724.25
Low (₹)590.10
Lower Circuit482.85
Prev Close603.55
52W High (₹)770.00
Price594.65
52W Low (₹)440.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)1207.79 Cr
Div. Yield (%)0.30
PE Ratio12.52
Debt to Equity0.00
Price to Book1.64
Book Value335.34
EPS (TTM)48.15
Face Value10.00
ROE (%)13.02

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
LUPINNSE
LINCOLNNSE
LTP
1W Low
1W High
Market cap (₹)
1849.9+12.6 (0.69%)
1832.20
1891.50
4,47,476Cr
9602+227 (2.42%)
9312.50
9740
2,54,764Cr
4928.5+88.5 (1.83%)
4848.50
5010
1,89,423Cr
1180.3+20.3 (1.75%)
1152.10
1190.60
1,16,658Cr
1399+4.5 (0.32%)
1364.50
1419
1,11,484Cr
2026.2+72.2 (3.69%)
1963.80
2055.30
1,09,943Cr
2500+199.3 (8.66%)
2303
2504.30
1,01,712Cr
1200.4+15.4 (1.30%)
1185
1222
1,01,005Cr
1716-18 (-1.04%)
1689.30
1740
99,253Cr
2100.7+17.7 (0.85%)
2080
2135
96,031Cr
594.65-10.2 (-1.69%)
590.10
612
1,208Cr

Lincoln Pharmaceuticals Ltd Annual Results Key Takeaways

Operating profit (before other income, interest and exceptional items) was ₹51.7Cr; with other income of ₹24.27Cr, profit before interest and tax came to ₹47.81Cr. Interest expense was ₹25.9Lakh; PBT before exceptional items stood at ₹47.55Cr. Cost mix (full year): raw materials ₹193.82Cr; employee cost ₹112.45Cr; depreciation ₹3.88Cr; other expenses ₹149.85Cr. Basis: consolidated annual results.

Lincoln Pharmaceuticals Ltd Quaterly Results Key Takeaways

Lincoln Pharmaceuticals Ltd reported ₹177.28Cr total income from operations in Jun 2026, softer than ₹187.28Cr in Mar 2026 but higher than ₹154.07Cr in Jun 2025. Operating profit (before other income, interest and exceptional items) was ₹51.7Cr; with other income of ₹24.27Cr, profit before interest and tax came to ₹47.81Cr. Interest expense was ₹25.9Lakh, taking profit before tax to ₹47.55Cr. After tax of ₹11.32Cr, profit after tax stood at ₹36.23Cr (vs ₹11.63Cr in Mar 2026 and ₹27.68Cr in Jun 2025).